Articles Tagged With:
-
New rapid-deployment plasma protocol in ED
While traumatic injury is the leading cause of death among people under age 45, if given plasma quickly, they will have a better chance at survival. Now, a new protocol from the American College of Surgeons aims to reduce the average wait time of 30 minutes or longer for plasma.
-
FORCE-TJR gets CMS qualification
The national hip and knee joint replacement registry has received certification from CMS as a Qualified Clinical Data Registry.
-
Can you teach doctors to improve patient satisfaction?
A study in the May issue of the Journal of Hospital Medicine may give hope to physicians and the hospitals where they work that they can learn the skills needed to improve the scores related to their interactions in the Hospital Consumer Assessment of Healthcare Providers and Systems surveys.
-
Hospital Compare starts with stars
The first group of star ratings are out for Hospital Compare, CMS’ hospital rating system.
-
Incentivize patients and they will walk
There is ample evidence that early walking can help surgical patients avoid complications like ileus, deep vein thrombosis and pneumonia.
-
Stop the Racket
A coalition of organizations involved in surgery is worried about how new technologies increase the noise and distraction levels in the operating room and otherwise affect patient safety and privacy.
-
ASQ healthcare costs and quality survey findings
Read the story behind the survey's findings here.
-
ASQ health survey highlights communication, patient experience
The link between quality, the patient experience, and satisfaction received more data support in April with the release of the American Society of Quality’s healthcare survey report.
-
Patient experience gains a foothold
There was a time, very recently, when Jason Wolf, PhD, the president of the Beryl Institute in Washington, DC, could talk about patient experience and people would think he was referring to the food you get in hospitals or whether the parking was easy. But it goes beyond that.
-
Beta-blocker, Shmeta-blocker…Or Are There Important Differences?
Whether clinicians should choose pharmacotherapy based on central BP effects has not been confirmed, although hypertension guidelines throughout the world have increasingly recognized the inadequacy of traditional beta-blockers in comparison to most other classes of agents and relegated them to a lower position on the therapeutic ladder.